A revolutionary immunotherapy, Car T-cell therapy, is demonstrating impressive results in fighting solid tumors.
This treatment genetically modifies a patient's own cells to attack and eliminate cancer cells more effectively.
Clinical trials show patients with advanced stomach cancer lived about 40% longer than those using standard treatments.
While further research is needed, this breakthrough offers substantial hope for improving survival rates for various cancers.
